IL128917A - Heteroaryloxyethylamines as 5-ht1a receptor ligands, a process for their preparation and pharmaceutical compositions containing them - Google Patents
Heteroaryloxyethylamines as 5-ht1a receptor ligands, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL128917A IL128917A IL12891797A IL12891797A IL128917A IL 128917 A IL128917 A IL 128917A IL 12891797 A IL12891797 A IL 12891797A IL 12891797 A IL12891797 A IL 12891797A IL 128917 A IL128917 A IL 128917A
- Authority
- IL
- Israel
- Prior art keywords
- heteroaryloxyethylamines
- preparation
- pharmaceutical compositions
- compositions containing
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611798A FR2753968B1 (fr) | 1996-09-27 | 1996-09-27 | Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| PCT/FR1997/001691 WO1998013349A2 (fr) | 1996-09-27 | 1997-09-26 | Heteroaryloxyethylamines en tant que ligands 5-ht¿1a? |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL128917A0 IL128917A0 (en) | 2000-02-17 |
| IL128917A true IL128917A (en) | 2003-10-31 |
Family
ID=9496126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12891797A IL128917A (en) | 1996-09-27 | 1997-09-26 | Heteroaryloxyethylamines as 5-ht1a receptor ligands, a process for their preparation and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6063784A (xx) |
| EP (1) | EP0929525B1 (xx) |
| JP (1) | JP2001503393A (xx) |
| AR (1) | AR008486A1 (xx) |
| AT (1) | ATE223380T1 (xx) |
| AU (1) | AU731459B2 (xx) |
| BR (1) | BR9711560A (xx) |
| CA (1) | CA2267247C (xx) |
| DE (1) | DE69715223T2 (xx) |
| DK (1) | DK0929525T3 (xx) |
| ES (1) | ES2182120T3 (xx) |
| FR (1) | FR2753968B1 (xx) |
| HU (1) | HUP0001189A3 (xx) |
| IL (1) | IL128917A (xx) |
| MY (1) | MY118992A (xx) |
| NO (1) | NO311935B1 (xx) |
| NZ (1) | NZ334623A (xx) |
| PL (1) | PL190221B1 (xx) |
| RU (1) | RU2176639C2 (xx) |
| TW (1) | TW425390B (xx) |
| WO (1) | WO1998013349A2 (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4507398B2 (ja) * | 1999-12-06 | 2010-07-21 | 宇部興産株式会社 | ３−ハロメチルオキセタン化合物の合成方法 |
| US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
| MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| US5240800A (en) * | 1991-07-29 | 1993-08-31 | Eastman Kodak Company | Near-infrared radiation sensitive photoelectrographic master and imaging method |
| GB9507288D0 (en) * | 1995-04-07 | 1995-05-31 | Sod Conseils Rech Applic | Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors |
-
1996
- 1996-09-27 FR FR9611798A patent/FR2753968B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-24 AR ARP970104385A patent/AR008486A1/es unknown
- 1997-09-25 MY MYPI97004469A patent/MY118992A/en unknown
- 1997-09-26 AU AU44637/97A patent/AU731459B2/en not_active Ceased
- 1997-09-26 IL IL12891797A patent/IL128917A/xx not_active IP Right Cessation
- 1997-09-26 ES ES97943000T patent/ES2182120T3/es not_active Expired - Lifetime
- 1997-09-26 CA CA002267247A patent/CA2267247C/fr not_active Expired - Fee Related
- 1997-09-26 DE DE69715223T patent/DE69715223T2/de not_active Expired - Lifetime
- 1997-09-26 TW TW086114116A patent/TW425390B/zh not_active IP Right Cessation
- 1997-09-26 DK DK97943000T patent/DK0929525T3/da active
- 1997-09-26 US US09/254,787 patent/US6063784A/en not_active Expired - Fee Related
- 1997-09-26 NZ NZ334623A patent/NZ334623A/en unknown
- 1997-09-26 WO PCT/FR1997/001691 patent/WO1998013349A2/fr active IP Right Grant
- 1997-09-26 PL PL97332480A patent/PL190221B1/pl not_active IP Right Cessation
- 1997-09-26 JP JP51535198A patent/JP2001503393A/ja not_active Withdrawn
- 1997-09-26 EP EP97943000A patent/EP0929525B1/fr not_active Expired - Lifetime
- 1997-09-26 RU RU99108674/04A patent/RU2176639C2/ru not_active IP Right Cessation
- 1997-09-26 HU HU0001189A patent/HUP0001189A3/hu unknown
- 1997-09-26 AT AT97943000T patent/ATE223380T1/de not_active IP Right Cessation
- 1997-09-26 BR BR9711560A patent/BR9711560A/pt active Search and Examination
-
1999
- 1999-03-26 NO NO19991481A patent/NO311935B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ334623A (en) | 1999-09-29 |
| NO991481D0 (no) | 1999-03-26 |
| DK0929525T3 (da) | 2002-12-02 |
| CA2267247C (fr) | 2009-05-05 |
| HUP0001189A3 (en) | 2001-12-28 |
| BR9711560A (pt) | 1999-08-24 |
| FR2753968B1 (fr) | 1998-11-27 |
| FR2753968A1 (fr) | 1998-04-03 |
| WO1998013349A3 (fr) | 1998-11-05 |
| PL190221B1 (pl) | 2005-11-30 |
| NO311935B1 (no) | 2002-02-18 |
| ATE223380T1 (de) | 2002-09-15 |
| WO1998013349A2 (fr) | 1998-04-02 |
| AR008486A1 (es) | 2000-01-19 |
| AU4463797A (en) | 1998-04-17 |
| TW425390B (en) | 2001-03-11 |
| RU2176639C2 (ru) | 2001-12-10 |
| IL128917A0 (en) | 2000-02-17 |
| MY118992A (en) | 2005-02-28 |
| US6063784A (en) | 2000-05-16 |
| ES2182120T3 (es) | 2003-03-01 |
| CA2267247A1 (fr) | 1998-04-02 |
| JP2001503393A (ja) | 2001-03-13 |
| AU731459B2 (en) | 2001-03-29 |
| EP0929525B1 (fr) | 2002-09-04 |
| EP0929525A2 (fr) | 1999-07-21 |
| PL332480A1 (en) | 1999-09-13 |
| HUP0001189A2 (hu) | 2000-10-28 |
| DE69715223T2 (de) | 2003-04-30 |
| NO991481L (no) | 1999-03-26 |
| DE69715223D1 (de) | 2002-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
| HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP9603494A3 (en) | Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof | |
| HUP9802422A3 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
| HUP0100394A3 (en) | 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof | |
| IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
| HUP9603495A2 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
| HUP0102512A3 (en) | Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0003608A2 (en) | Tetrahydroisoquinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9901739A3 (en) | Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them | |
| HUP9602635A2 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP9802757A3 (en) | New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1039122A1 (zh) | 取代的6-苄基-4-氧代嘧啶，其製備方法以及含該化合物的藥物組合物 | |
| HUP9902784A3 (en) | Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0104202A3 (en) | Thiazole-derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HU9601331D0 (en) | New piperazine- and homeopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9600173A3 (en) | 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them | |
| HUP0003766A2 (en) | Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them | |
| HU9503318D0 (en) | Arthropocidal compounds, compositions containing them and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |